Halo Neuroscience Secures $9,000,000 Series A Funding

  • Feed Type
  • Date
    2/11/2016
  • Company Name
    Halo Neuroscience
  • Mailing Address
    33 W. 17th Street 4th Floor New York, NY 10011 USA
  • Company Description
    Neuromodulation technology that elevates cognitive performance. Halo is developing a novel, simple, and powerful neuroscience-based technology for enhancing performance on cognitive tasks, for the healthy and impaired.
  • Website
    http://www.haloneuro.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Lux Capital
  • Venture Investor
    Andreessen Horowitz
  • Venture Investor
    JAZZ Venture Partners
  • Venture Investor
    SoftTech VC
  • Venture Investor
    Xfund

Trending on Xconomy